stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Gain Therapeutics IncGANX
$0.99944.82%-0.0506
After Hours: 1.11+0.11 +11.07%

Gain Therapeutics Inc (GANX)

Gain Therapeutics Inc Stock (GANX) Forecast

The Gain Therapeutics Inc (GANX) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $0.6464, representing a -35.33% decrease from the current price of $0.9994. The highest analyst price target is $0.7326, and the lowest is $0.5601.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month GANX Price Target
Average 1.91 (+91.17% Downside)

Is Gain Therapeutics Inc (GANX) A Buy Now?

Oscillators
NameValueAction
RSI(14)39.03Neutral
STOCH(9,6)32.99Neutral
STOCHRSI(14)65.21Neutral
MACD(12,26)-0.09Buy
ADX(14)26.95Sell
William %R-83.52Buy
CCI(14)-53.07Neutral
Buy: 2 · Sell: 1 · Neutral: 4Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
1.07
Sell
1.07
Sell
MA20
1.09
Sell
1.13
Sell
MA50
1.40
Sell
1.33
Sell
MA100
1.61
Sell
1.52
Sell
MA200
1.80
Sell
1.72
Sell
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, GANX could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 11 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on GANX, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 39.03 indicates that GANX is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 32.99 indicates that GANX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 65.21 indicates that GANX is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of 26.95 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
  5. CCI (Commodity Channel Index): A CCI(14) value of -53.07 indicates that GANX is still oversold but not to an extreme extent.

Long-term GANX price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Gain Therapeutics Inc financial reports and earnings history, Gain Therapeutics Inc (GANX) stock could reach $2.38 by 2030, $10.89 by 2040 and $28.06 by 2050. See the projected annual prices until 2050 of the Gain Therapeutics Inc stock below:

  • Gain Therapeutics Inc (GANX) is expected to reach an average price of $4.62 in 2035, with a high prediction of $6.15 and a low estimate of $3.65. This indicates an +362.44% change from the last recorded price of $0.9994.
  • Gain Therapeutics Inc (GANX) stock is projected to chart a bullish course in 2040, with an average price target of $8.69, representing an +769.94% change from its current level. The forecast ranges from a conservative $7.73 to a sky-high $10.89.
  • Our analysts predict Gain Therapeutics Inc (GANX) to change +1,396% by 2045, soaring from $15.05 to an average price of $14.95, potentially reaching $19.31. While $15.05 is the low estimate, the potential upside is significant.
  • Gain Therapeutics Inc (GANX) stock is expected to climb by 2050, reaching an average of $22.37, a +2,139% change from its current level. However, a wide range of estimates exists, with high and low targets of $28.06 and $22.27, respectively, highlighting the market's uncertainty.

Gain Therapeutics Inc Stock (GANX) Year by Year Forecast

Gain Therapeutics Inc Stock (GANX) Price Forecast for 2026

The predicted value for Gain Therapeutics Inc (GANX) in 2026 is set at an average of $1.67. Estimates vary from a peak of $3.29 to a trough of $0.3, indicating an +66.98% surge from the present price of $0.9994.

MonthAverageLowHighChange from today's price
December, 2026$1.01$0.5601$0.7326+0.58%

Gain Therapeutics Inc Stock (GANX) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Gain Therapeutics Inc (GANX) is $2.43, with a high forecast of $3.26 and a low forecast of $1.35. This indicates an +143.50% increase from the last price of $0.9994.

MonthAverageLowHighChange from today's price
January, 2027$2.25$1.35$1.71+125.16%
February, 2027$2.39$2.54$2.42+139.19%
March, 2027$3.03$2.80$2.74+203.24%
April, 2027$2.09$2.36$2.42+109.20%
May, 2027$2.83$2.44$2.62+183.26%
June, 2027$3.20$3.32$3.26+220.29%
July, 2027$2.18$2.55$2.66+118.24%
August, 2027$1.80$2.22$2.27+80.24%
September, 2027$2.26$1.98$1.72+126.28%
October, 2027$1.96$2.36$2.21+96.27%
November, 2027$2.59$2.14$2.30+159.33%
December, 2027$2.61$2.40$2.46+161.34%

Gain Therapeutics Inc Stock (GANX) Price Forecast for 2028

In 2028, Gain Therapeutics Inc (GANX) is projected to reach an average price of $1.02, with a high projection of $2.50 and a low estimate of $0.0828. This indicates an +1.84% rise from the last price of $0.9994.

MonthAverageLowHighChange from today's price
January, 2028$2.32$2.55$2.50+132.34%
February, 2028$2.35$2.44$2.37+135.35%
March, 2028$1.33$1.57$2.19+33.31%
April, 2028$1.20$1.43$1.28+20.31%
May, 2028$0.6026$1.14$1.15-39.71%
June, 2028$0.3527$0.5626$0.2426-64.71%
July, 2028$0.0729$0.0828$1.07-92.71%
August, 2028$0.113$0.2029$0.2526-88.70%
September, 2028$0.2331$0.243$0.177-76.68%
October, 2028$0.9533$0.4631$0.8033-4.62%
November, 2028$1.39$1.25$0.9933+39.42%
December, 2028$1.28$1.28$1.18+28.43%

Gain Therapeutics Inc Stock (GANX) Price Forecast for 2029

The 2029 price forecast for Gain Therapeutics Inc Stock (GANX) is $1.33 on average, with a high prediction of $2.51 and a low estimate of $0.0265. This represents an +32.79% increase from the previous price of $0.9994.

MonthAverageLowHighChange from today's price
January, 2029$1.63$1.44$1.39+63.47%
February, 2029$1.74$1.70$1.58+74.49%
March, 2029$1.64$2.19$2.12+64.49%
April, 2029$0.7741$0.9841$1.58-22.54%
May, 2029$0.2442$0.4942$0.4641-75.56%
June, 2029$0.3856$0.0265$1.17-61.41%
July, 2029$0.2345$0.1076$1.13-76.53%
August, 2029$0.8947$0.5345$0.6246-10.48%
September, 2029$1.21$1.01$1.01+21.55%
October, 2029$2.45$1.45$2.36+145.64%
November, 2029$2.46$2.46$2.44+145.66%
December, 2029$2.25$2.58$2.51+124.66%

Gain Therapeutics Inc Stock (GANX) Price Forecast for 2030

Gain Therapeutics Inc Stock (GANX) is expected to reach an average price of $1.04 in 2030, with a high forecast of $2.38 and a low forecast of $0.6862. This signifies an +4.30% surge from the last price of $0.9994.

MonthAverageLowHighChange from today's price
January, 2030$2.02$2.27$2.38+102.16%
February, 2030$1.59$1.80$1.92+58.65%
March, 2030$0.8256$0.8156$1.23-17.39%
April, 2030$1.37$1.01$1.33+36.66%
May, 2030$1.39$1.60$1.44+38.68%
June, 2030$0.7861$0.956$0.8378-21.35%
July, 2030$0.6962$0.6862$0.7461-30.34%
August, 2030$0.5463$0.7498$0.7963-45.33%
September, 2030$0.9865$1.01$1.01-1.29%
October, 2030$0.7666$0.7165$0.7787-23.29%
November, 2030$0.7068$0.8676$0.7967-29.28%
December, 2030$0.8369$0.7469$0.7568-16.26%

Similar to GANX